Relationship of adipokines with insulin sensitivity in African Americans

American Journal of the Medical Sciences

Volumn 342, Issue 3, 2011, Pages 192-197

  Martinez Cantarin, Maria P ^a,b   Keith, Scott W ^b   Deloach, Stephanie ^a   Huan, Yonghong ^a   Falkner, Bonita ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Adipokines; Adiposity; Insulin resistance

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; CYTOKINE; GLUCOSE; INSULIN; INTERLEUKIN 6; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; AFRICAN AMERICAN; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; BLOOD SAMPLING; BODY FAT; BODY MASS; CONTROLLED STUDY; DIET RESTRICTION; EUGLYCEMIC HYPERINSULINEMIC INSULIN CLAMP; FEMALE; GEOMETRIC MEAN RATIO; GEOMETRY; GLUCOSE CLAMP TECHNIQUE; HUMAN; IMMUNOASSAY; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; RISK FACTOR;

EID: 80052263019     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3182112bcd     Document Type: Article

References (48)

1. Das UN. Is obesity an inflammatory condition? Nutrition 2001;17: 953-66. (Pubitemid 34020662)
2. Yudkin JS, Stehouwer CD, Emeis JJ, et al. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction: A potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999;19:972-8. (Pubitemid 29177345)
3. Kern PA, Saghizadeh M, Ong JM, et al. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 1995;95: 2111-9.
4. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005;115:1111-9. (Pubitemid 40629025)
5. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257:79-83. (Pubitemid 29299050)
6. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance. Science 1993;259:87-91. (Pubitemid 23036092)
7. Hotamisligil GS, Arner P, Caro JF, et al. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995;95:2409-15.
8. Festa A, D'Agostino R Jr, Howard G, et al. Chronic subclinical inflammation as part of the insulin resistance syndrome: The Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000;102:42-7. (Pubitemid 30430551)
9. Rocha VZ, Libby P. Obesity, inflammation, and atherosclerosis. Nat Rev Cardiol 2009;6:399-409.
10. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest 2006;116:1793-801. (Pubitemid 44033299)
11. Scherer PE, Williams S, Fogliano M, et al. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995;270:26746-9.
12. Yamauchi T, Kamon J, Minokoshi Y, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002;8:1288-95. (Pubitemid 35373562)
13. Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001;7:941-6. (Pubitemid 32756432)
14. Yamauchi T, Kamon J, Waki H, et al. Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J Biol Chem 2003;278:2461-8. (Pubitemid 36801322)
15. Fruebis J, Tsao TS, Javorschi S, et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA 2001;98:2005-10. (Pubitemid 32165613)
16. Kubota N, Terauchi Y, Yamauchi T, et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 2002; 277:25863-6. (Pubitemid 34967064)
17. Mather KJ, Funahashi T, Matsuzawa Y, et al. Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program. Diabetes 2008;57:980-6.
18. Hulver MW, Saleh O, MacDonald KG, et al. Ethnic differences in adiponectin levels. Metabolism 2004;53:1-3. (Pubitemid 38071928)
19. Smith LM, Yao-Borengasser A, Starks T, et al. Insulin resistance in African-American and Caucasian women: Differences in lipotoxicity, adipokines, and gene expression in adipose tissue and muscle. J Clin Endocrinol Metab 2010;95:4441-8.
20. Huan Y, Falkner B. Insulin resistance predicts deterioration in glucose tolerance in non-diabetic young African Americans. Metabolism 2009; 58:689-95.
21. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214 -23. (Pubitemid 9249478)
22. Rizza RA, Mandarino LJ, Gerich JE. Dose-response characteristics for effects of insulin on production and utilization of glucose in man. Am J Physiol 1981;240:E630 -9.
23. Durnin JV, Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness: Measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 1974;32:77-97.
24. Diagnosis and classification of diabetes mellitus. Diabetes Care 2006; 29(suppl 1):S43- 8.
25. Lee S, Bacha F, Gungor N, et al. Racial differences in adiponectin in youth: Relationship to visceral fat and insulin sensitivity. Diabetes Care 2006;29:51-6. (Pubitemid 44033430)
26. Kowalska I, Straczkowski M, Nikolajuk A, et al. Insulin resistance, serum adiponectin, and proinflammatory markers in young subjects with the metabolic syndrome. Metabolism 2008;57:1539-44.
27. Li S, Shin HJ, Ding EL, et al. Adiponectin levels and risk of type 2 diabetes: A systematic review and meta-analysis. JAMA 2009;302: 179-88.
28. Frystyk J, Berne C, Berglund L, et al. Serum adiponectin is a predictor of coronary heart disease: A population-based 10-year follow- up study in elderly men. J Clin Endocrinol Metab 2007;92:571-6.
29. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001;86:1930 -5. (Pubitemid 32472900)
30. Stefan N, Vozarova B, Funahashi T, et al. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes 2002;50: 1884-8. (Pubitemid 34564302)
31. Tschritter O, Fritsche A, Thamer C, et al. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 2003;52:239-43. (Pubitemid 36173174)
32. Abbasi F, Chu JW, Lamendola C, et al. Discrimination between obesity and insulin resistance in the relationship with adiponectin. Diabetes 2004;53:585-90. (Pubitemid 38270626)
33. Considine RV, Premkumar A, Reynolds JC, et al. Adiponectin and leptin in African Americans. Obesity (Silver Spring) 2008;16:428-34. (Pubitemid 351271927)
34. Bush NC, Darnell BE, Oster RA, et al. Adiponectin is lower among African Americans and is independently related to insulin sensitivity in children and adolescents. Diabetes 2005;54:2772-8. (Pubitemid 41233601)
35. Osei K, Gaillard T, Schuster D. Plasma adiponectin levels in high risk African-Americans with normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes. Obes Res 2005;13:179-85.
36. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: Comparison with the euglycemic insulin clamp. Diabetes Care 1999;22:1462-70. (Pubitemid 29418240)
37. Quon MJ. Limitations of the fasting glucose to insulin ratio as an index of insulin sensitivity. J Clin Endocrinol Metab 2001;86:4615-7. (Pubitemid 33020494)
38. Cheng C, Campbell KL, Kushner H, et al. Correlation of oral glucose tolerance test-derived estimates of insulin sensitivity with insulin clamp measurements in an African-American cohort. Metabolism 2004;53: 1107-12. (Pubitemid 39140741)
39. Natali A, Toschi E, Baldeweg S, et al. Clustering of insulin resistance with vascular dysfunction and low-grade inflammation in type 2 diabetes. Diabetes 2006;55:1133-40. (Pubitemid 44100192)
40. Haffner SM. The metabolic syndrome: Inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol 2006;97:3A-11A. (Pubitemid 43139714)
41. Pscherer S, Heemann U, Frank H. Effect of renin-angiotensin system blockade on insulin resistance and inflammatory parameters in patients with impaired glucose tolerance. Diabetes Care 2010;33:914-9.
42. Bastard JP, Jardel C, Bruckert E, et al. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 2000;85:3338-42.
43. Kopp HP, Kopp CW, Festa A, et al. Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscler Thromb Vasc Biol 2003;23:1042-7. (Pubitemid 36713558)
44. Vozarova B, Weyer C, Hanson K, et al. Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res 2001;9:414-7. (Pubitemid 33603868)
45. Evans EM, Rowe DA, Racette SB, et al. Is the current BMI obesity classification appropriate for black and white postmenopausal women? Int J Obes 2006;30:837-43.
46. Haffner SM, D'Agostino R, Saad MF, et al. Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study. Diabetes 1996;45:742-8.
47. Flegal KM, Shepherd JA, Looker AC, et al. Comparisons of percentage body fat, body mass index, waist circumference, and waiststature ratio in adults. Am J Clin Nutr 2009;89:500-8.
48. Ussai KE, Keith SW, Pequignot E, et al. Risk factors associated with urinary albumin excretion in African Americans. J Hum Hypertens 2011;25:1-2.